177 related articles for article (PubMed ID: 15971289)
1. Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.
Hirabayashi Y; Tsuchiya K; Kimura S; Oka S
Biomed Chromatogr; 2006 Jan; 20(1):28-36. PubMed ID: 15971289
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
[TBL] [Abstract][Full Text] [Related]
4. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 2005 Apr; 27(2):186-92. PubMed ID: 15795650
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite.
Verbesselt R; Van Wijngaerden E; de Hoon J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):51-60. PubMed ID: 16997640
[TBL] [Abstract][Full Text] [Related]
6. Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection.
Dailly E; Raffi F; Jolliet P
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):353-8. PubMed ID: 15556553
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
Dailly E; Thomas L; Kergueris MF; Jolliet P; Bourin M
J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):129-35. PubMed ID: 11486821
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
Ther Drug Monit; 2002 Jun; 24(3):417-24. PubMed ID: 12021635
[TBL] [Abstract][Full Text] [Related]
9. Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.
Colombo S; Beguin A; Telenti A; Biollaz J; Buclin T; Rochat B; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):259-76. PubMed ID: 15833290
[TBL] [Abstract][Full Text] [Related]
10. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
Weller DR; Brundage RC; Balfour HH; Vezina HE
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.
Droste JA; Verweij-Van Wissen CP; Burger DM
Ther Drug Monit; 2003 Jun; 25(3):393-9. PubMed ID: 12766571
[TBL] [Abstract][Full Text] [Related]
12. Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
ter Heine R; Alderden-Los CG; Rosing H; Hillebrand MJ; van Gorp EC; Huitema AD; Beijnen JH
Rapid Commun Mass Spectrom; 2007; 21(15):2505-14. PubMed ID: 17610214
[TBL] [Abstract][Full Text] [Related]
13. Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
Villani P; Feroggio M; Gianelli L; Bartoli A; Montagna M; Maserati R; Regazzi MB
Ther Drug Monit; 2001 Aug; 23(4):380-8. PubMed ID: 11477320
[TBL] [Abstract][Full Text] [Related]
14. Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma.
Keil K; Frerichs VA; DiFrancesco R; Morse G
Ther Drug Monit; 2003 Jun; 25(3):340-6. PubMed ID: 12766563
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma.
Rezk NL; Tidwell RR; Kashuba AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):241-7. PubMed ID: 15135096
[TBL] [Abstract][Full Text] [Related]
16. Conventional HPLC method used for simultaneous determination of the seven HIV protease inhibitors and nonnucleoside reverse transcription inhibitor efavirenz in human plasma.
Takahashi M; Yoshida M; Oki T; Okumura N; Suzuki T; Kaneda T
Biol Pharm Bull; 2005 Jul; 28(7):1286-90. PubMed ID: 15997115
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography.
Justesen US; Pedersen C; Klitgaard NA
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(2):491-500. PubMed ID: 12482492
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography-mass spectrometry.
Rouzes A; Berthoin K; Xuereb F; Djabarouti S; Pellegrin I; Pellegrin JL; Coupet AC; Augagneur S; Budzinski H; Saux MC; Breilh D
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):209-16. PubMed ID: 15556535
[TBL] [Abstract][Full Text] [Related]
20. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G
J Pharm Biomed Anal; 2011 Mar; 54(4):779-88. PubMed ID: 21071165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
